Biotech Spain  Items tag "cancer"

News
Roche invests up to $1.2B in Foundation Medicine
14/01/2015
Collaboration leverages both companies' strengths to advance the progress of personalized treatments for patients with cancer.
  View more
A possible new therapeutic target for MYC-associated cancers
09/01/2014
A possible new therapeutic target for MYC-associated cancers According to a recent publication, the cells with high levels of MYC dependent on MCL-1 protein to survive.
  View more
Key relationship between a tumor-specific protein and cell division unveiled.
11/12/2013
Key relationship between a tumor-specific protein and cell division unveiled. PKM2 protein, commonly activated in tumors, has a vital role in cell division, survival and tumor development.
  View more
Inhibition of antioxidants could be a viable alternative for cancer treatment.
03/12/2013
Inhibition of antioxidants could be a viable alternative for cancer treatment. A research paper reports the effect of a pharmacological inhibitor of SOD1 enzyme in cells of non-small cell lung (NSCLC) cancer.
  View more
New advances in the understanding of the DNA protection mechanisms during replication.
25/11/2013
New advances in the understanding of the DNA protection mechanisms during replication. An international team of researchers describes how the availability of the RPA protein is critical to protect DNA during replication.
  View more
A new molecular mechanism for regulating cell migration in cancer cells.
21/11/2013
A new molecular mechanism for regulating cell migration in cancer cells. PRH protein is able to prevent cells from migrating unnecessarily. This protein may be less effective in cancer cells, allowing their spreading.
  View more
MerTK inhibition could contribute to anti-cancer therapy
09/07/2013
MerTK inhibition could contribute to anti-cancer therapy A recent study with mouse models deficient in MerTK shows that the absence of this protein increases the antitumor response and slows tumor growth and spreading.
  View more
Why do naked mole rats are cancer-proof
21/06/2013
Why do naked mole rats are cancer-proof Naked mole rats are small hairless rodents of subterranean habits, which have never shown signs of cancer, despite having a life expectancy of 30 years. Recent research describes the chemical that makes this possible.
  View more
Master regulator of metastasis unveiled.
11/06/2013
Master regulator of metastasis unveiled. Transcription factor Sox4 triggers the expression of a number of genes that play a central role in the process of metastasis.
  View more
A new class of drugs to treat advanced prostate cancer.
29/05/2013
A new class of drugs to treat advanced prostate cancer. A new class of drugs has been described that interrupt sthe intracellular signaling necessary to the growth of prostate cancer cells.
  View more
Redirecting drugs to mitochondria as a strategy to fight cancer.
24/05/2013
Redirecting drugs to mitochondria as a strategy to fight cancer. Chemotherapeutic redirection into mitochondria might circumvent the problem of resistance in many cancer therapies.
  View more
Neural Stem Cells are able to deliver anti cancer drugs to glioma
19/05/2013
Neural Stem Cells are able to deliver anti cancer drugs to glioma High-grade gliomas are a very invasive and almost incurable tumor. Trying to be able to treat the tumors with higher doses of chemotherapy based in a tumor specific delivery is a new research area. Here the authors demonstrate in mice that Neural Stem Cells are a good vehicle because its tumor tropism and safety.
  View more
Poor regulation of the cellular cytoskeleton may be important in the development of cancer.
09/05/2013
Poor regulation of the cellular cytoskeleton may be important in the development of cancer. A recent research identifies a new molecular mechanism by which Src oncogene activity is controlled by the cell's cytoskeleton.
  View more
A new agreement to develop cancer drugs based on antibodies.
06/05/2013
A new agreement to develop cancer drugs based on antibodies. The pharmaceutical Bristol-Myers Squibb (BMS) will use technology from Ambrx to develop antibody-drug conjugates (ADC) for use in cancer treatment. The collaboration will peak at 112 million dollars and it is the third among these companies.
  View more
Colby and Mannkind sign agreement to develop and market products for cancer immunotherapy
16/11/2012
Colby and Mannkind sign agreement to develop and market products for cancer immunotherapy Colby Pharmaceutical Company and MannKind Corporation (Nasdaq: MNKD) today announced a license agreement granting Colby exclusive worldwide rights to develop and commercialize disease-specific antigen compounds and intra-lymph node delivery technologies from MannKind’s novel MKC1106 active immunotherapy programs.
  View more
New perspectives for cancer treatment.
20/04/2012
New perspectives for cancer treatment. A recent scientific work suggests the possibility of treating cancerous tumors without affecting other tissues.
  View more
A new gene associated with development of myelodysplasia.
27/09/2011
A new gene associated with development of myelodysplasia. Recent research has discovered new mutations associated with the development of myelodysplasia.
  View more
Cellular balance in tumors is stochastic
19/08/2011
Cellular balance in tumors is stochastic A recent study shows that in tumors, maintaining the balance between cell phenotypes is stochastic and any cell type within a given tumor is interchangeable with others.
  View more
Fundamental Spanish advance in the understanding of chronic lymphocytic leukemia
06/06/2011
Fundamental Spanish advance in the understanding of chronic lymphocytic leukemia By using genomic sequencing techniques, a group of Spanish researchers has identified four mutations associated with this type of leukemia.
  View more
Genetic rearrangements and breast cancer.
08/04/2011
Genetic rearrangements and breast cancer. A combination of sequencing technologies along with deep sequence analysis gives more insights about the role of genetic aberration in the development of breast cancer.
  View more
Microvesicles generated by tumors carry genetic material.
23/02/2011
Microvesicles generated by tumors carry genetic material. A study has shown that inside the content of microvesicles secreted by tumors it can be found relevant genetic information in the shape of DNA from mobile genetic elements. This information can be absorbed by normal cells.
  View more
Events
Next Generation Sequencing For Cancer Drug Development
24/09/2013 - 26/09/2013
Boston, MA
Next Generation Sequencing For Cancer Drug Development A comprehensive guide to applying NGS in cancer drug discovery and clinical diagnostic development. Discussions about solutions to help you choose the best technology for the smoothest transition of NGS technology towards the clinic.
  View more
American Society of Clinical Oncology (ASCO) 2012 Annual Meeting
01/06/2012 - 05/06/2012
Chicago, EE. UU.
American Society of Clinical Oncology (ASCO) 2012 Annual Meeting The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Collaborating to Conquer Cancer."
  View more
3rd Conference on Therapeutic Resistance in Cancer
15/03/2012 - 16/03/2012
Montreal, Canadá
3rd Conference on Therapeutic Resistance in Cancer This year’s conference, held in Montreal, Canada, will bring together clinicians and basic researchers working in translational research, to explore the importance of therapeutic resistance in cancer, in the pursuit of personalized medicine.
  View more
Stem Cells, Development and Cancer
03/03/2011 - 06/03/2011
Vancouver, Canada
Stem Cells, Development and Cancer This event is expected to explore the latest knowledge regarding relationship between stem cells and cancer progression, appart from studying their function in development and tissue maintenance.
  View more
News about our members
Enzymlogic to take part in the VI SDDN Meeting Enzymlogic
19/11/2014
Enzymlogic to take part in the VI SDDN Meeting Enzymlogic to be present at the next Spanish Drug Discovery Network Meeting to share ideas and explore new tools that will add real value to its customers' drug discovery projects.
  View more
Presentation of Era7's new service for Cancer Genomics, Genome7, in BioSpain 2014 Era7 Information Technologies SLU
14/10/2014
Presentation of Era7's new service for Cancer Genomics, Genome7, in BioSpain 2014 On 24 September 2014 Eduardo Pareja, CEO of Era7, presented for the first time in BioSpain 2014 (Santiago de Compostela) in a press conference Era7’s new service for Cancer Genomics, Genome7.
  View more
The results of BIOBIDE´s participation in the European FP7 project (ZF-Cancer) have been published in Oncoge. BIOBIDE
23/01/2012
The results of BIOBIDE´s participation in the European FP7 project (ZF-Cancer) have been published in Oncoge. The results obtained by Biobide in collaboration with the Center for Regenerative Medicine in Barcelona, the Biotech Galapagos and the Salk Institute for Biological Studies (USA) , have been published in the prestigious journal ONCOGENE.
  View more
BIOBIDE has been selected to present in the “European Cancer Cluster partnering” (ECCP) that will be celebrated in Toulouse, France from September 14th to 16th BIOBIDE
06/09/2011
BIOBIDE has been selected to present in the “European Cancer Cluster partnering” (ECCP) that will be celebrated in Toulouse, France from September 14th to 16th
  View more